Physiological immune components

Physiological immune components refer to the collective set of cells, tissues, and molecules—such as antibodies, cytokines, and the complement system—that constitute the immune system (Janeway et al., 2001). This term does not describe a single molecular target but rather a complex, integrated network responsible for protecting the host from pathogenic organisms and maintaining tissue homeostasis (NIH, 2023). In a therapeutic context, various drugs are designed to modulate specific parts of this system to treat conditions ranging from autoimmune disorders and chronic inflammation to cancer and infectious diseases (StatPearls, 2023). Because the term encompasses a vast array of distinct proteins and cell types, it is considered a broad biological category rather than a specific pharmacological target. Understanding the interplay between these components is crucial for developing targeted immunotherapies that can selectively enhance or suppress immune activity without causing systemic toxicity (PubMed, 2022).

Other names

Immune systemImmune componentsHost defense systemImmune effector mechanisms

Drugs targeting physiological immune components act through diverse mechanisms including the inhibition of specific cytokines, modulation of T-cell or B-cell activity, and blockade of immune checkpoints to either suppress or stimulate the immune response (StatPearls, 2023; NIH, 2023).